CLOTTING ACTIVATION AND IMPAIRMENT OF FIBRINOLYSIS IN MALIGNANCY

被引:44
作者
ROCHA, E
PARAMO, JA
FERNANDEZ, FJ
CUESTA, B
HERNANDEZ, M
PALOMA, MJ
RIFON, J
机构
关键词
D O I
10.1016/0049-3848(89)90134-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:699 / 707
页数:9
相关论文
共 39 条
[1]   THE FIBRIN PLATE METHOD FOR ESTIMATING FIBRINOLYTIC ACTIVITY [J].
ASTRUP, T ;
MULLERTZ, S .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1952, 40 (02) :346-351
[2]  
BAUER KA, 1984, BLOOD, V64, P791
[3]   REGULATION OF THE FIBRINOLYTIC SYSTEM OF CULTURED HUMAN VASCULAR ENDOTHELIUM BY INTERLEUKIN-1 [J].
BEVILACQUA, MP ;
SCHLEEF, RR ;
GIMBRONE, MA ;
LOSKUTOFF, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (02) :587-591
[4]   THE CLINICAL-SIGNIFICANCE OF FIBRINOGEN DEGRADATION PRODUCTS [J].
BICK, RL .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1982, 8 (04) :302-330
[5]   EVIDENCE THAT CELLS FROM EXPERIMENTAL-TUMORS CAN ACTIVATE COAGULATION FACTOR-X [J].
CURATOLO, L ;
COLUCCI, M ;
CAMBINI, AL ;
POGGI, A ;
MORASCA, L ;
DONATI, MB ;
SEMERARO, N .
BRITISH JOURNAL OF CANCER, 1979, 40 (02) :228-233
[6]  
DEJONG E, 1987, THROMB HAEMOSTASIS, V57, P140
[7]   MALIGNANCY AND HEMOSTASIS [J].
DONATI, MB ;
POGGI, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1980, 44 (02) :173-182
[8]   PLASMINOGEN-ACTIVATOR AND CANCER [J].
DUFFY, MJ ;
OGRADY, P .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (05) :577-582
[9]   RELEASE OF A 2-CHAIN FORM OF ANTI-THROMBIN FROM THE ANTITHROMBIN-THROMBIN COMPLEX [J].
FISH, WW ;
BJORK, I .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1979, 101 (01) :31-38
[10]   FIBRINOGEN SPLIT PRODUCTS, ANTIPROTEASES AND GRANULOCYTIC ELASTASE IN PATIENTS WITH LUNG-CANCER [J].
GROPP, C ;
EGBRING, R ;
HAVEMANN, K .
EUROPEAN JOURNAL OF CANCER, 1980, 16 (05) :679-&